(E)-(tert-Butoxy)[cyclopropyl(6-cyclopropylpyridin-3-yl)methylidene]amine

Catalog No. :
ACBKPO218
CAS No. :
900019-86-5
Molecular Formula :
C16H22N2O
Molecular Weight :
258.36

IUPAC Name:(E)-cyclopropyl(6-cyclopropylpyridin-3-yl)methanone O-(tert-butyl) oxime

(E)-(tert-Butoxy)[cyclopropyl(6-cyclopropylpyridin-3-yl)methylidene]amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$334.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-(tert-Butoxy)[cyclopropyl(6-cyclopropylpyridin-3-yl)methylidene]amine
IUPAC Name(E)-cyclopropyl(6-cyclopropylpyridin-3-yl)methanone O-(tert-butyl) oxime
MDL No.MFCD06496146
Molecular FormulaC16H22N2O
Molecular Weight258.36
SMILESCC(O/N=C(C1CC1)/C2=CC=C(C3CC3)N=C2)(C)C
InChI KeyXIMFDUBOBZOZJT-OBGWFSINSA-N
Synonym(E)-(tert-butoxy)[cyclopropyl(6-cyclopropylpyridin-3-yl)methylidene]amine;Methanone, cyclopropyl(6-cyclopropyl-3-pyridinyl)-, O-(1,1-dimethylethyl)oxime
CAS No.900019-86-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBKPO218 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9 In Stock
  4. Then
  5. ACBKPO218 route product structure diagram
    ACBKPO218900019-86-5
Inquiry

2. ACBKPO218 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRDVN638 route compound structure diagram
    ACRDVN638579475-29-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBKPO218 route product structure diagram
    ACBKPO218900019-86-5
Inquiry

Comments (0)